Coastlands Capital LP → OnKure Therapeutics, Inc. OKUR

Stake: — Shares: — Class: Class A Common Stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

7 13D/G filings on this issuer

6 other filings besides this one

Filer Track Record

6 filings by this filer

5 other filings in the data moat

Short Interest · settle 2026-09-30

DTC 4.76

1,223,923 shares short · -11.0% vs prior

Other 13D/G Filings on OnKure Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2026-05-27	SCHEDULE 13G	BIOTECHNOLOGY VALUE FUND L P	—	—	view →
2026-04-07	SCHEDULE 13D	AI Biotechnology LLC	19.99%	9,091,532	view →
2025-01-21	SCHEDULE	RiverVest Venture Fund III, L.P.	1.55%	196,198	view →
2024-10-08	SC	New Enterprise Associates 15, L.P.	—	—	view →
2023-05-30	SC	RiverVest Venture Fund III, L.P.	—	—	view →
2022-01-27	SC	Novo Holdings A/S	—	—	view →

Other Filings by Coastlands Capital LP

Filed	Form	Issuer	Stake	Shares
2026-10-05	SCHEDULE 13G	Pyxis Oncology, Inc.	—	—	view →
2026-07-01	SCHEDULE 13G/A	Adial Pharmaceuticals, Inc. ADIL	—	—	view →
2026-07-01	SCHEDULE 13G/A	Pasithea Therapeutics Corp. KTTAW	—	—	view →
2026-06-24	SCHEDULE 13G	Adial Pharmaceuticals, Inc. ADIL	—	—	view →
2026-06-17	SCHEDULE 13G	Eloxx Pharmaceuticals, Inc. ELOX	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →